Logo
Glycomic Therapeutics Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Glycomic Therapeutics Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Glycomic Therapeutics Market by Class (Isolated, Synthetic), Structure (Glycoprotein, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Targeting Glycosylphosphatidylinositol (GPI) - Anchored Proteins and Heparin Based Glycans, Targeting Glycosphingolipids, Others), Indication (Thrombosis and Chemoprophylaxis, Anaemia, Anti-adhesive and Anti-inflammatory, Cataracts, Gaucher’s disease, Others) Mode of Action, and Regional Analysis from 2026 to 2033

ID: PMRREP33227
Calendar

February 2026

206 Pages

Author : Pravin Rewale

Healthcare
  1. Executive Summary
    1. Global Glycomic Therapeutics Market Snapshot, 2026 and 2033
    2. Market Opportunity Assessment, 2026 - 2033, US$ Mn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Regulatory Landscape
    2. Product Adoption Analysis
    3. Value Chain Analysis
    4. Key Deals and Mergers
    5. PESTLE Analysis
    6. Porter’s Five Force Analysis
  4. Global Glycomic Therapeutics Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2020-2025
      2. Market Size (US$ Mn) Analysis and Forecast, 2026-2033
    3. Global Glycomic Therapeutics Market Outlook: Class
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Class, 2020-2025
      3. Market Size (US$ Mn) Analysis and Forecast, By Class, 2026-2033
        1. Isolated
        2. Synthetic
      4. Market Attractiveness Analysis: Class
    4. Global Glycomic Therapeutics Market Outlook: Structure
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Structure, 2020-2025
      3. Market Size (US$ Mn) Analysis and Forecast, By Structure, 2026-2033
        1. Glycoproteins
        2. Targeting Sialic Acid
        3. Proteoglycans
        4. Targeting Glycosaminoglycans
        5. Targeting Glycosylphosphatidylinositol (GPI) - Anchored Proteins and Heparin Based Glycans
        6. Targeting Glycosphingolipids
        7. Others
      4. Market Attractiveness Analysis: Structure
    5. Global Glycomic Therapeutics Market Outlook: Indication
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Indication, 2020-2025
      3. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
        1. Thrombosis and Chemoprophylaxis
        2. Anaemia
        3. Anti-adhesive and Anti-inflammatory
        4. Cataracts
        5. Gaucher’s disease
        6. Others
      4. Market Attractiveness Analysis: Indication
    6. Global Glycomic Therapeutics Market Outlook: Mode of Action
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Mode of Action, 2020-2025
      3. Market Size (US$ Mn) Analysis and Forecast, By Mode of Action, 2026-2033
        1. Inhibits Neuraminidase
        2. Inhibits Heparanase and Selectins and Blocks Interactions between Growth Factors and Heparan Sulfate
        3. Erythropoietin and Enzyme Replacement Therapy
        4. Tissue Plasminogen Activator
        5. Others
      4. Market Attractiveness Analysis: Mode of Action
  5. Global Glycomic Therapeutics Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Region, 2020-2025
    3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2026-2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Glycomic Therapeutics Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Class
      3. By Structure
      4. By Indication
      5. By Mode of Action
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
      1. U.S.
      2. Canada
    4. Market Size (US$ Mn) Analysis and Forecast, By Class, 2026-2033
      1. Isolated
      2. Synthetic
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
      1. Glycoproteins
      2. Targeting Sialic Acid
      3. Proteoglycans
      4. Targeting Glycosaminoglycans
      5. Targeting Glycosylphosphatidylinositol (GPI) - Anchored Proteins and Heparin Based Glycans
      6. Targeting Glycosphingolipids
      7. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By Structure, 2026-2033
      1. Thrombosis and Chemoprophylaxis
      2. Anaemia
      3. Anti-adhesive and Anti-inflammatory
      4. Cataracts
      5. Gaucher’s disease
      6. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By Mode of Action, 2026-2033
      1. Inhibits Neuraminidase
      2. Inhibits Heparanase and Selectins and Blocks Interactions between Growth Factors and Heparan Sulfate
      3. Erythropoietin and Enzyme Replacement Therapy
      4. Tissue Plasminogen Activator
      5. Others
    8. Market Attractiveness Analysis
  7. Europe Glycomic Therapeutics Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Class
      3. By Structure
      4. By Indication
      5. By Mode of Action
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    4. Market Size (US$ Mn) Analysis and Forecast, By Class, 2026-2033
      1. Isolated
      2. Synthetic
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
      1. Glycoproteins
      2. Targeting Sialic Acid
      3. Proteoglycans
      4. Targeting Glycosaminoglycans
      5. Targeting Glycosylphosphatidylinositol (GPI) - Anchored Proteins and Heparin Based Glycans
      6. Targeting Glycosphingolipids
      7. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By Structure, 2026-2033
      1. Thrombosis and Chemoprophylaxis
      2. Anaemia
      3. Anti-adhesive and Anti-inflammatory
      4. Cataracts
      5. Gaucher’s disease
      6. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By Mode of Action, 2026-2033
      1. Inhibits Neuraminidase
      2. Inhibits Heparanase and Selectins and Blocks Interactions between Growth Factors and Heparan Sulfate
      3. Erythropoietin and Enzyme Replacement Therapy
      4. Tissue Plasminogen Activator
      5. Others
    8. Market Attractiveness Analysis
  8. East Asia Glycomic Therapeutics Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Class
      3. By Structure
      4. By Indication
      5. By Mode of Action
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Mn) Analysis and Forecast, By Class, 2026-2033
      1. Isolated
      2. Synthetic
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
      1. Glycoproteins
      2. Targeting Sialic Acid
      3. Proteoglycans
      4. Targeting Glycosaminoglycans
      5. Targeting Glycosylphosphatidylinositol (GPI) - Anchored Proteins and Heparin Based Glycans
      6. Targeting Glycosphingolipids
      7. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By Structure, 2026-2033
      1. Thrombosis and Chemoprophylaxis
      2. Anaemia
      3. Anti-adhesive and Anti-inflammatory
      4. Cataracts
      5. Gaucher’s disease
      6. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By Mode of Action, 2026-2033
      1. Inhibits Neuraminidase
      2. Inhibits Heparanase and Selectins and Blocks Interactions between Growth Factors and Heparan Sulfate
      3. Erythropoietin and Enzyme Replacement Therapy
      4. Tissue Plasminogen Activator
      5. Others
    8. Market Attractiveness Analysis
  9. South Asia & Oceania Glycomic Therapeutics Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Class
      3. By Structure
      4. By Indication
      5. By Mode of Action
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Mn) Analysis and Forecast, By Class, 2026-2033
      1. Isolated
      2. Synthetic
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
      1. Glycoproteins
      2. Targeting Sialic Acid
      3. Proteoglycans
      4. Targeting Glycosaminoglycans
      5. Targeting Glycosylphosphatidylinositol (GPI) - Anchored Proteins and Heparin Based Glycans
      6. Targeting Glycosphingolipids
      7. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By Structure, 2026-2033
      1. Thrombosis and Chemoprophylaxis
      2. Anaemia
      3. Anti-adhesive and Anti-inflammatory
      4. Cataracts
      5. Gaucher’s disease
      6. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By Mode of Action, 2026-2033
      1. Inhibits Neuraminidase
      2. Inhibits Heparanase and Selectins and Blocks Interactions between Growth Factors and Heparan Sulfate
      3. Erythropoietin and Enzyme Replacement Therapy
      4. Tissue Plasminogen Activator
      5. Others
    8. Market Attractiveness Analysis
  10. Latin America Glycomic Therapeutics Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Class
      3. By Structure
      4. By Indication
      5. By Mode of Action
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Mn) Analysis and Forecast, By Class, 2026-2033
      1. Isolated
      2. Synthetic
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
      1. Glycoproteins
      2. Targeting Sialic Acid
      3. Proteoglycans
      4. Targeting Glycosaminoglycans
      5. Targeting Glycosylphosphatidylinositol (GPI) - Anchored Proteins and Heparin Based Glycans
      6. Targeting Glycosphingolipids
      7. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By Structure, 2026-2033
      1. Thrombosis and Chemoprophylaxis
      2. Anaemia
      3. Anti-adhesive and Anti-inflammatory
      4. Cataracts
      5. Gaucher’s disease
      6. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By Mode of Action, 2026-2033
      1. Inhibits Neuraminidase
      2. Inhibits Heparanase and Selectins and Blocks Interactions between Growth Factors and Heparan Sulfate
      3. Erythropoietin and Enzyme Replacement Therapy
      4. Tissue Plasminogen Activator
      5. Others
    8. Market Attractiveness Analysis
  11. Middle East & Africa Glycomic Therapeutics Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Class
      3. By Structure
      4. By Indication
      5. By Mode of Action
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Mn) Analysis and Forecast, By Class, 2026-2033
      1. Isolated
      2. Synthetic
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
      1. Glycoproteins
      2. Targeting Sialic Acid
      3. Proteoglycans
      4. Targeting Glycosaminoglycans
      5. Targeting Glycosylphosphatidylinositol (GPI) - Anchored Proteins and Heparin Based Glycans
      6. Targeting Glycosphingolipids
      7. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By Structure, 2026-2033
      1. Thrombosis and Chemoprophylaxis
      2. Anaemia
      3. Anti-adhesive and Anti-inflammatory
      4. Cataracts
      5. Gaucher’s disease
      6. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By Mode of Action, 2026-2033
      1. Inhibits Neuraminidase
      2. Inhibits Heparanase and Selectins and Blocks Interactions between Growth Factors and Heparan Sulfate
      3. Erythropoietin and Enzyme Replacement Therapy
      4. Tissue Plasminogen Activator
      5. Others
    8. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. Intellihep Ltd
        1. Overview
        2. Segments and Products
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Protalix Biotherapeutics
      3. BioMarin Pharmaceutical Inc.
      4. Genzyme Corporation (Sanofi)
      5. Halozyme Therapeutics, Inc.
      6. Bayer AG
      7. Alzheon, Inc.
      8. GlycoMar
      9. GlaxoSmithKline plc
      10. Others
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
Emailsales@persistencemarketresearch.com
UK

Second Floor, 150 Fleet Street,
London, EC4A 2DQ.

+44 203-837-5656
USA

108 W 39th Street, Ste 1006,
PMB2219, New York, NY 10018

+1 646-878-6329
India

IT Unit No. 504, 5th Floor, Icon
Tower, Baner, Pune - 411045.

+91 906 779 3500
Quick Links
CareersTerms & ConditionsReturn Policy Market Research Report
Customer FAQ’sPrivacy Policy Sitemap

Copyright © 2026 Persistence Market Research. All Rights Reserved

Connect With Us -